Eli Lilly and Company Company Information
Eli Lilly and Company's employee growth, exchange listings and data sources
Key Information
- Name: Eli Lilly and Company
- Ticker: LLY
- Exchange: BASE
- Founded: 1876
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$691.316b
- Listing Market Cap: US$706.663t
- Shares Outstanding: 900.43m
- Website: https://www.lilly.com
Number of Employees
Location
- Eli Lilly and Company
- Lilly Corporate Center
- Indianapolis
- Indiana
- 46285
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| LLY | NYSE (New York Stock Exchange) | Yes | Common Stock | US | USD | Jan 1969 |
| LLY | SWX (SIX Swiss Exchange) | Yes | Common Stock | CH | CHF | Jan 1969 |
| LLY * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Jan 1969 |
| 0Q1G | LSE (London Stock Exchange) | Yes | Common Stock | GB | CHF | Jan 1969 |
| LLY | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jan 1969 |
| LLY | XTRA (XETRA Trading Platform) | Yes | Common Stock | DE | EUR | Jan 1969 |
| LLYZ | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Common Stock | GB | CHF | Jan 1969 |
| 4LLY | ETLX (Eurotlx) | Yes | Common Stock | IT | EUR | Jan 1969 |
| LLYC | WBAG (Wiener Boerse AG) | Yes | Common Stock | AT | EUR | Jan 1969 |
| LLY | BUL (Bulgaria Stock Exchange) | Yes | Common Stock | BG | EUR | Jan 1969 |
| LLYD | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Common Stock | GB | EUR | Jan 1969 |
| LLY | BVL (Bolsa de Valores de Lima) | Yes | Common Stock | PE | USD | Jan 1969 |
| LLYCL | SNSE (Santiago Stock Exchange) | Yes | Common Stock | CL | CLP | Jan 1969 |
| LLY | SNSE (Santiago Stock Exchange) | Yes | Common Stock | CL | USD | Jan 1969 |
| LLY | BASE (Buenos Aires Stock Exchange) | CEDEAR EACH 56 REP 1 | AR | ARS | Jul 2001 | |
| LLYD | BASE (Buenos Aires Stock Exchange) | CEDEAR EACH 56 REP 1 | AR | USD | Jul 2001 | |
| LILY34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH 30 REPR 1 COM | BR | BRL | Aug 2012 | |
| LLY | NEOE (Aequitas Neo Exchange) | Cdr Cad Hedged Reg S | CA | CAD | Nov 2023 | |
| LLY0 | DB (Deutsche Boerse AG) | Cdr Cad Hedged Reg S | DE | EUR | Nov 2023 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 21:18 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 21:18 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Eli Lilly and Company is covered by 63 analysts. 29 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Ishan Majumdar | Baptista Research |
| Alistair Campbell | Berenberg |